Chemical Structure (Daybue 01)
Daybue Solution
Product Images NDC 63090-660
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Daybue (NDC 63090-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Acadia Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Daybue 02)
The text appears to be a table showing the change from baseline for a study comparing a placebo to a treatment called "DAYBUE". The study was conducted over 12 weeks and includes data on the number of patients. Unfortunately, it is unclear what the units of measurement are or what is being measured. Therefore, a useful description cannot be provided.*
Figure 2 (Daybue 03)
This is a report of a study that evaluates two groups of patients (1004 W DAYBUE and Placebo) with N=77 and N=86 respectively. The report presents several percentages and scores related to the study, including the score on the CGI-scale at week 12. The text also includes a table with seven categories ranging from "very much improved" to "very much worse."*
Principal Display Panel (450 mL Bottle Carton)
This is a description of Daybue, an oral solution containing 200mg/mL of trofinetide. Each bottle contains 450mL of the solution and it must be stored refrigerated between 2°C to 8°C. The solution is intended for oral or gastronomy-tube administration. The NDC number for the product is 63080-660-01.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
